Download PDF
Am J Perinatol 2019; 36(06): 641-646
DOI: 10.1055/s-0038-1673397
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Mystery of Patent Ductus Arteriosus and Serum Osmolality in Preterm Infants

Ufuk Cakir
1   Division of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey
,
Cuneyt Tayman
1   Division of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey
› Author Affiliations Funding None.
Further Information

Publication History

23 July 2018

29 August 2018

Publication Date:
06 October 2018 (online)

    Permissions and Reprints

Abstract

Objective Patent ductus arteriosus (PDA) is an important clinical problem associated with mortality and serious morbidities. It is thought that serum osmolality may affect ductal patency. We aimed to investigate the importance of serum osmolality related to ductal patency in preterm infants.

Study Design Our study was conducted between January 2013 and December 2017. Premature infants with birth weight <1,500 g and gestational age <32 weeks were included in the study. Serum osmolality was compared between infants with hemodynamically significant PDA (hsPDA) and non-hsPDA.

Results During the study period, 799 patients were evaluated. Mean serum osmolality levels were higher in the “hsPDA” group (297 ± 10.9 vs. 292 ± 8.3 mOsm/L) (p = 0.001). The area under the curve for osmolality was 0.582 (p = 0.0006, 95% confidence interval: 0.541–0.622) at the time of diagnosis for predicting hsPDA, with a cutoff value for osmolality of 300 mOsm/L.

Conclusion Serum osmolality may be recognized as an important contributing factor for ductal patency especially among extremely preterm infants who are most likely to have hsPDA in the early days of life.

Keywords

hemodynamically significant patent ductus arteriosus - premature - serum osmolality - very low birth weight
 

  • References

  • 1 Mezu-Ndubuisi OJ, Agarwal G, Raghavan A, Pham JT, Ohler KH, Maheshwari A. Patent ductus arteriosus in premature neonates. Drugs 2012; 72 (07) 907-916
    CrossrefPubMedGoogle Scholar
  • 2 Evans N. Preterm patent ductus arteriosus: a continuing conundrum for the neonatologist?. Semin Fetal Neonatal Med 2015; 20 (04) 272-277
    CrossrefPubMedGoogle Scholar
  • 3 Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010; 125 (05) 1020-1030
    CrossrefPubMedGoogle Scholar
  • 4 Nemri AM. Patent ductus arteriosus in preterm infant: basic pathology and when to treat. Sudan J Paediatr 2014; 14 (01) 25-30
    PubMedGoogle Scholar
  • 5 Echtler K, Stark K, Lorenz M. , et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 2010; 16 (01) 75-82
    CrossrefPubMedGoogle Scholar
  • 6 Alyamac Dizdar E, Ozdemir R, Sari FN. , et al. Low platelet count is associated with ductus arteriosus patency in preterm newborns. Early Hum Dev 2012; 88 (10) 813-816
    CrossrefPubMedGoogle Scholar
  • 7 Bas-Suárez MP, González-Luis GE, Saavedra P, Villamor E. Platelet counts in the first seven days of life and patent ductus arteriosus in preterm very low-birth-weight infants. Neonatology 2014; 106 (03) 188-194
    CrossrefPubMedGoogle Scholar
  • 8 Simon SR, van Zogchel L, Bas-Suárez MP, Cavallaro G, Clyman RI, Villamor E. Platelet counts and patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology 2015; 108 (02) 143-151
    CrossrefPubMedGoogle Scholar
  • 9 Kahvecioglu D, Erdeve O, Akduman H. , et al. Influence of platelet count, platelet mass index, and platelet function on the spontaneous closure of ductus arteriosus in the prematurity. Pediatr Neonatol 2018; 59 (01) 53-57
    CrossrefPubMedGoogle Scholar
  • 10 Feldman W, Drummond KN. Serum and urine osmolality in normal full-term infants. Can Med Assoc J 1969; 101 (10) 73-74
    PubMedGoogle Scholar
  • 11 Aoki R, Yokoyama U, Ichikawa Y. , et al. Decreased serum osmolality promotes ductus arteriosus constriction. Cardiovasc Res 2014; 104 (02) 326-336
    CrossrefPubMedGoogle Scholar
  • 12 Posencheg MA, Evans JR. Acid-base, fluid and electrolyte management. In: Gleason CA, Devaskar SU. , eds. Avery's Diseases of the Newborn. Philadelphia: Elsevier Saunders; 2012: 367-389
    CrossrefGoogle Scholar
  • 13 Lapillonne A, Berleur MP, Brasseur Y, Calvez S. Safety of parenteral nutrition in newborns: results from a nationwide prospective cohort study. Clin Nutr 2018; 37 (02) 624-629
    CrossrefPubMedGoogle Scholar
  • 14 Dargaville PA, Gerber A, Johansson S. , et al; Australian and New Zealand Neonatal Network. Incidence and outcome of CPAP failure in preterm infants. Pediatrics 2016; 138 (01) e20153985
    CrossrefPubMedGoogle Scholar
  • 15 Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 2003; 23 (06) 451-456
    CrossrefPubMedGoogle Scholar
  • 16 International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123 (07) 991-999
    CrossrefPubMedGoogle Scholar
  • 17 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92 (04) 529-534
    CrossrefPubMedGoogle Scholar
  • 18 Kliegman RM, Walsh MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 1987; 17 (04) 213-288
    PubMedGoogle Scholar
  • 19 Bhat R, Das UG. Management of patent ductus arteriosus in premature infants. Indian J Pediatr 2015; 82 (01) 53-60
    CrossrefPubMedGoogle Scholar
  • 20 Kluckow M, Lemmers P. Hemodynamic assessment of the patent ductus arteriosus: Beyond ultrasound. Semin Fetal Neonatal Med 2018; 23 (04) 239-244
    CrossrefPubMedGoogle Scholar
  • 21 Lee N, Chen J, Sun L. , et al. Expression and characterization of human transient receptor potential melastatin 3 (hTRPM3). J Biol Chem 2003; 278 (23) 20890-20897
    CrossrefPubMedGoogle Scholar
  • 22 Naylor J, Li J, Milligan CJ. , et al. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction. Circ Res 2010; 106 (09) 1507-1515
    CrossrefPubMedGoogle Scholar
  • 23 Wagner TF, Drews A, Loch S. , et al. TRPM3 channels provide a regulated influx pathway for zinc in pancreatic beta cells. Pflugers Arch 2010; 460 (04) 755-765
    CrossrefPubMedGoogle Scholar
  • 24 Majeed Y, Tumova S, Green BL. , et al. Pregnenolone sulphate-independent inhibition of TRPM3 channels by progesterone. Cell Calcium 2012; 51 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 25 Klose C, Straub I, Riehle M. , et al. Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3. Br J Pharmacol 2011; 162 (08) 1757-1769
    CrossrefPubMedGoogle Scholar
  • 26 Stephens BE, Gargus RA, Walden RV. , et al. Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants. J Perinatol 2008; 28 (02) 123-128
    CrossrefPubMedGoogle Scholar
  • 27 Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2008; 1 (01) CD000503
    PubMedGoogle Scholar
  • 28 Hammarlund K, Sedin G, Strömberg B. Transepidermal water loss in newborn infants. VIII. Relation to gestational age and post-natal age in appropriate and small for gestational age infants. Acta Paediatr Scand 1983; 72 (05) 721-728
    CrossrefPubMedGoogle Scholar
  • 29 Bonilla-Felix M. Development of water transport in the collecting duct. Am J Physiol Renal Physiol 2004; 287 (06) F1093-F1101
    CrossrefPubMedGoogle Scholar
  • 30 Baumgart S, Langman CB, Sosulski R, Fox WW, Polin RA. Fluid, electrolyte, and glucose maintenance in the very low birth weight infant. Clin Pediatr (Phila) 1982; 21 (04) 199-206
    CrossrefPubMedGoogle Scholar